These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31871084)

  • 1. Evaluation of the Activity of a Combination of Three Bacteriophages Alone or in Association with Antibiotics on Staphylococcus aureus Embedded in Biofilm or Internalized in Osteoblasts.
    Kolenda C; Josse J; Medina M; Fevre C; Lustig S; Ferry T; Laurent F
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871084
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiological and ultrastructural evaluation of bacteriophage 191219 against planktonic, intracellular and biofilm infection with Staphylococcus aureus.
    Mannala GK; Rupp M; Walter N; Brunotte M; Alagboso F; Docheva D; Brochhausen C; Alt V
    Eur Cell Mater; 2022 Feb; 43():66-78. PubMed ID: 35201606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting intracellular Staphylococcus aureus to lower recurrence of orthopaedic infection.
    Dusane DH; Kyrouac D; Petersen I; Bushrow L; Calhoun JH; Granger JF; Phieffer LS; Stoodley P
    J Orthop Res; 2018 Apr; 36(4):1086-1092. PubMed ID: 28885721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity against intraosteoblastic Staphylococcus aureus.
    Valour F; Trouillet-Assant S; Riffard N; Tasse J; Flammier S; Rasigade JP; Chidiac C; Vandenesch F; Ferry T; Laurent F
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2029-36. PubMed ID: 25605365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.
    Schuch R; Khan BK; Raz A; Rotolo JA; Wittekind M
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus.
    Tkhilaishvili T; Lombardi L; Klatt AB; Trampuz A; Di Luca M
    Int J Antimicrob Agents; 2018 Dec; 52(6):842-853. PubMed ID: 30236955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
    Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
    Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
    Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK; Mermel LA; LaPlante KL
    Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care.
    Seth AK; Geringer MR; Nguyen KT; Agnew SP; Dumanian Z; Galiano RD; Leung KP; Mustoe TA; Hong SJ
    Plast Reconstr Surg; 2013 Feb; 131(2):225-234. PubMed ID: 23357984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
    Abad L; Tafani V; Tasse J; Josse J; Chidiac C; Lustig S; Ferry T; Diot A; Laurent F; Valour F
    J Antimicrob Chemother; 2019 Mar; 74(3):625-632. PubMed ID: 30517641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against
    Kumaran D; Taha M; Yi Q; Ramirez-Arcos S; Diallo JS; Carli A; Abdelbary H
    Front Microbiol; 2018; 9():127. PubMed ID: 29459853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin.
    Rahman M; Kim S; Kim SM; Seol SY; Kim J
    Biofouling; 2011 Nov; 27(10):1087-93. PubMed ID: 22050201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
    Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
    Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom.
    van der Plas MJ; Dambrot C; Dogterom-Ballering HC; Kruithof S; van Dissel JT; Nibbering PH
    J Antimicrob Chemother; 2010 May; 65(5):917-23. PubMed ID: 20189943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Ethoxybenzoic acid inhibits Staphylococcus aureus biofilm formation and potentiates biofilm sensitivity to vancomycin.
    Campbell M; Cho CY; Ho A; Huang JY; Martin B; Gilbert ES
    Int J Antimicrob Agents; 2020 Sep; 56(3):106086. PubMed ID: 32663508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased tolerance of Staphylococcus aureus to vancomycin in viscous media.
    Kostenko V; Ceri H; Martinuzzi RJ
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):277-88. PubMed ID: 17727657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.